113 related articles for article (PubMed ID: 14647669)
1. [Assessing the efficacy of the recombinant human granulocyte colony-stimulating factor "rhG-CSF" in the treatment of early neonatal sepsis in premature neonates].
Miura E; Procianoy RS; Bittar C; Miura CS; Melo C; Miura MS
J Pediatr (Rio J); 2000; 76(3):193-9. PubMed ID: 14647669
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
Gathwala G; Walia M; Bala H; Singh S
J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
[TBL] [Abstract][Full Text] [Related]
6. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
7. Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis.
Cairo MS; Plunkett JM; Nguyen A; van de Ven C
Blood; 1992 Jul; 80(1):96-101. PubMed ID: 1377057
[TBL] [Abstract][Full Text] [Related]
8. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
[TBL] [Abstract][Full Text] [Related]
9. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM
Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096
[TBL] [Abstract][Full Text] [Related]
10. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
[TBL] [Abstract][Full Text] [Related]
11. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia.
Bedford Russell AR; Emmerson AJ; Wilkinson N; Chant T; Sweet DG; Halliday HL; Holland B; Davies EG
Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F172-6. PubMed ID: 11320043
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia.
Khan TH; Shahidullah M; Mannan MA; Nahar N
Mymensingh Med J; 2012 Jul; 21(3):469-74. PubMed ID: 22828545
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia.
Teng RJ; Wu TJ; Sharma R; Garrison RD; Hudak ML
J Formos Med Assoc; 2015 Feb; 114(2):174-9. PubMed ID: 25678180
[TBL] [Abstract][Full Text] [Related]
16. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
Ahmad M; Fleit HB; Golightly MG; La Gamma EF
Biol Neonate; 2004; 86(1):48-54. PubMed ID: 15057022
[TBL] [Abstract][Full Text] [Related]
17. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
Cairo MS; Plunkett JM; Schendel P; van de Ven C
Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
19. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
Ahmad A; Laborada G; Bussel J; Nesin M
Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
Huang W; Liu J; Zeng Y; Wu F; Li N; Chen K; Hong Y; Wang L; Zhen H; Lin L
Cancer Chemother Pharmacol; 2018 Oct; 82(4):607-613. PubMed ID: 30043207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]